Overview Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women Status: Completed Trial end date: 2009-01-01 Target enrollment: Participant gender: Summary This study is designed to evaluate the endometrial safety of a testosterone patch as treatment for low libido in naturally postmenopausal women. Phase: Phase 3 Details Lead Sponsor: Warner ChilcottTreatments: MethyltestosteroneTestosteroneTestosterone 17 beta-cypionateTestosterone enanthateTestosterone undecanoate